FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897521722> ?p ?o ?g. }

• W2897521722 endingPage "7270" @default.
• W2897521722 startingPage "7255" @default.
• W2897521722 abstract "Thymosin α1 (Tα1) is one of the most commonly used immunomodulators for metastatic non-small-cell lung cancer (NSCLC) patients in many countries. Despite the identification of the direct suppression on cancer cell proliferation, little is known about its effect on metastasis and metastasis-related signaling such as matrix metalloproteinases (MMPs) and programmed cell death ligand 1 (PD-L1).NSCLC cells with distinguishing PD-L1 expression levels were treated with Tα1. siRNAs were used to knockdown PD-L1. Cell migration and invasion abilities were evaluated by wound-healing and transwell assays. The xenograft model by BALB/c nude mice was constructed to test the inhibitory effect of Tα1 on metastasis in vivo. The expression levels of metastasis-related signaling pathways and key molecules were assessed by Western blot (WB) and quantitative reverse transcriptase PCR (qRT-PCR).Tα1 significantly suppressed cell migration and invasion in PD-L1 high-expressing H1299, NL9980, and L9981 cells but not in PD-L1 low-expressing A549 or SPC-A-1 cells. This difference was demonstrated by mouse model in vivo as well. Knocking down of PD-L1 significantly impaired the inhibition of cell migration and invasion caused by Tα1 treating in PD-L1 high-expressing cells. Besides, Tα1 inhibited the activation and translocation of STAT3 and the expression of MMP2 in PD-L1 high-expressing NSCLC cells. Moreover, the treatment of STAT3 activator colivelin could partly reverse the Tα1-induced MMP2 suppression and the migration phenotype.Tα1 significantly suppresses migration and invasion in PD-L1 high-expressing NSCLC cells compared with PD-L1 low-expressing NSCLC cells in vitro and in vivo, through the downregulation of STAT3-MMP2 signaling. These different responses to Tα1, together with the depiction of Tα1-induced signaling changes, suggest a potential benefit of Tα1 for PD-L1-positive NSCLC patients, enlightening the combination of Tα1 with target therapy or immune checkpoint inhibitors." @default.
• W2897521722 created "2018-10-26" @default.
• W2897521722 creator A5007605414 @default.
• W2897521722 creator A5022654613 @default.
• W2897521722 creator A5050103020 @default.
• W2897521722 creator A5072015275 @default.
• W2897521722 creator A5086186709 @default.
• W2897521722 date "2018-10-01" @default.
• W2897521722 modified "2023-10-15" @default.
• W2897521722 title "Thymosin &alpha;1 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3&ndash;MMP2 signaling" @default.
• W2897521722 cites W1416972792 @default.
• W2897521722 cites W1518617544 @default.
• W2897521722 cites W1520359069 @default.
• W2897521722 cites W1811917379 @default.
• W2897521722 cites W1833918915 @default.
• W2897521722 cites W1874696823 @default.
• W2897521722 cites W1881148218 @default.
• W2897521722 cites W1965742680 @default.
• W2897521722 cites W1968817120 @default.
• W2897521722 cites W1974813680 @default.
• W2897521722 cites W1978857579 @default.
• W2897521722 cites W1986709000 @default.
• W2897521722 cites W1986884128 @default.
• W2897521722 cites W1988508992 @default.
• W2897521722 cites W1996863944 @default.
• W2897521722 cites W2024492396 @default.
• W2897521722 cites W2026780005 @default.
• W2897521722 cites W2036062932 @default.
• W2897521722 cites W2088364705 @default.
• W2897521722 cites W2104692426 @default.
• W2897521722 cites W2130541026 @default.
• W2897521722 cites W2144330816 @default.
• W2897521722 cites W2149080433 @default.
• W2897521722 cites W2168635759 @default.
• W2897521722 cites W2272984102 @default.
• W2897521722 cites W2310774656 @default.
• W2897521722 cites W2409360168 @default.
• W2897521722 cites W243906112 @default.
• W2897521722 cites W245863835 @default.
• W2897521722 cites W2467123328 @default.
• W2897521722 cites W2501125746 @default.
• W2897521722 cites W2513437066 @default.
• W2897521722 cites W2588675203 @default.
• W2897521722 cites W2607045926 @default.
• W2897521722 cites W2607333782 @default.
• W2897521722 cites W2758499822 @default.
• W2897521722 cites W276343765 @default.
• W2897521722 cites W2774555410 @default.
• W2897521722 cites W2775921330 @default.
• W2897521722 cites W2784044161 @default.
• W2897521722 cites W4238604577 @default.
• W2897521722 doi "https://doi.org/10.2147/ott.s177943" @default.
• W2897521722 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6205819" @default.
• W2897521722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30425517" @default.
• W2897521722 hasPublicationYear "2018" @default.
• W2897521722 type Work @default.
• W2897521722 sameAs 2897521722 @default.
• W2897521722 citedByCount "20" @default.
• W2897521722 countsByYear W28975217222019 @default.
• W2897521722 countsByYear W28975217222020 @default.
• W2897521722 countsByYear W28975217222021 @default.
• W2897521722 countsByYear W28975217222022 @default.
• W2897521722 countsByYear W28975217222023 @default.
• W2897521722 crossrefType "journal-article" @default.
• W2897521722 hasAuthorship W2897521722A5007605414 @default.
• W2897521722 hasAuthorship W2897521722A5022654613 @default.
• W2897521722 hasAuthorship W2897521722A5050103020 @default.
• W2897521722 hasAuthorship W2897521722A5072015275 @default.
• W2897521722 hasAuthorship W2897521722A5086186709 @default.
• W2897521722 hasBestOaLocation W28975217221 @default.
• W2897521722 hasConcept C121608353 @default.
• W2897521722 hasConcept C126322002 @default.
• W2897521722 hasConcept C137738243 @default.
• W2897521722 hasConcept C1491633281 @default.
• W2897521722 hasConcept C173396325 @default.
• W2897521722 hasConcept C185592680 @default.
• W2897521722 hasConcept C203014093 @default.
• W2897521722 hasConcept C22615655 @default.
• W2897521722 hasConcept C2776451592 @default.
• W2897521722 hasConcept C2779013556 @default.
• W2897521722 hasConcept C2780699576 @default.
• W2897521722 hasConcept C502942594 @default.
• W2897521722 hasConcept C54009773 @default.
• W2897521722 hasConcept C54355233 @default.
• W2897521722 hasConcept C55493867 @default.
• W2897521722 hasConcept C71924100 @default.
• W2897521722 hasConcept C81885089 @default.
• W2897521722 hasConcept C86803240 @default.
• W2897521722 hasConceptScore W2897521722C121608353 @default.
• W2897521722 hasConceptScore W2897521722C126322002 @default.
• W2897521722 hasConceptScore W2897521722C137738243 @default.
• W2897521722 hasConceptScore W2897521722C1491633281 @default.
• W2897521722 hasConceptScore W2897521722C173396325 @default.
• W2897521722 hasConceptScore W2897521722C185592680 @default.
• W2897521722 hasConceptScore W2897521722C203014093 @default.
• W2897521722 hasConceptScore W2897521722C22615655 @default.
• W2897521722 hasConceptScore W2897521722C2776451592 @default.
• W2897521722 hasConceptScore W2897521722C2779013556 @default.

• next